Compounds > bezafibrate
Page last updated: 2024-08-23

bezafibrate and enalapril

bezafibrate has been researched along with enalapril in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Gagnon, C; Garcia-Ac, A; Sauvé, S; Segura, PA1
Furuyama, M; Hashimoto, T; Hayasaka, K; Matsunaga, A; Ogino, D; Toyoda, K1
Gagnon, C; Garcia-Ac, A; Sauvé, S; Segura, PA; Viglino, L1

Other Studies

4 other study(ies) available for bezafibrate and enalapril

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Determination of bezafibrate, methotrexate, cyclophosphamide, orlistat and enalapril in waste and surface waters using on-line solid-phase extraction liquid chromatography coupled to polarity-switching electrospray tandem mass spectrometry.
    Journal of environmental monitoring : JEM, 2009, Volume: 11, Issue:4

    Topics: Bezafibrate; Chromatography, Liquid; Cyclophosphamide; Enalapril; Environmental Monitoring; Lactones; Methotrexate; Orlistat; Solid Phase Extraction; Tandem Mass Spectrometry; Water; Water Pollutants, Chemical; Water Purification; Water Supply

2009
Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy.
    Clinical and experimental nephrology, 2009, Volume: 13, Issue:6

    Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Apolipoproteins E; Bezafibrate; Child; Child, Preschool; Enalapril; Female; Hematuria; Humans; Hypolipidemic Agents; Kidney Diseases; Kidney Failure, Chronic; Kidney Glomerulus; Nephrotic Syndrome; Probucol; Tetrazoles; Valine; Valsartan

2009
Comparison of APPI, APCI and ESI for the LC-MS/MS analysis of bezafibrate, cyclophosphamide, enalapril, methotrexate and orlistat in municipal wastewater.
    Journal of mass spectrometry : JMS, 2011, Volume: 46, Issue:4

    Topics: Bezafibrate; Chromatography, Liquid; Cyclophosphamide; Enalapril; Flow Injection Analysis; Lactones; Mass Spectrometry; Methotrexate; Orlistat; Sewage; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Water; Water Pollutants, Chemical

2011